Home > Insider Trading > Filing (0001209191-21-044561)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1783032	Elevation Oncology Inc.	ELEV	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1172252	N Andrew Schiff	C/O Aisling Capital Management Lp 888 Seventh Avenue, 12Th Floor New York NY 10106	No	No	No	Yes
1250195	Steve Elms	C/O Aisling Capital Management Lp 888 Seventh Avenue, 12Th Floor New York NY 10106	Yes	No	No	Yes
1652910	Aisling Capital Iv, Lp	888 Seventh Avenue 12Th Floor New York NY 10106	No	No	Yes	No
1737019	Aisling Capital Partners Iv Llc	888 Seventh Avenue 12Th Floor New York NY 10106	No	No	Yes	No
1737020	Aisling Capital Partners Iv, Lp	888 Seventh Avenue 12Th Floor New York NY 10106	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-06-29	1,893,232	$0.00	2,189,050	No	4	C	Direct
Common Stock	Acquisiton	2021-06-29	458,360	$0.00	2,647,410	No	4	C	Direct
Common Stock	Acquisiton	2021-06-29	187,500	$16.00	2,834,910	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2021-06-29	8,000,000	$0.00	1,893,232	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-06-29	1,936,834	$0.00	458,360	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date.
The securities are directly held by Aisling Capital IV, LP ("Aisling"). Aisling Capital Partners IV, LP ("Aisling GP"), is the general partner of Aisling, and Aisling Capital Partners IV LLC ("Aisling Partners"), is the general partner of Aisling GP. The managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms and may share voting power and dispositive powers over securities held by Aisling, and as a result, may be deemed to have beneficial ownership over such securities. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.